These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27580306)

  • 1. A novel option for prandial insulin therapy: inhaled insulin.
    Dailey G; Ahmad A; Polsky S; Shah V
    Postgrad Med; 2016 Nov; 128(8):839-847. PubMed ID: 27580306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents.
    Rosenstock J; Franco D; Korpachev V; Shumel B; Ma Y; Baughman R; Amin N; McGill JB;
    Diabetes Care; 2015 Dec; 38(12):2274-81. PubMed ID: 26253730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coverage of prandial insulin requirements by means of an ultra-rapid-acting inhaled insulin.
    Boss AH; Petrucci R; Lorber D
    J Diabetes Sci Technol; 2012 Jul; 6(4):773-9. PubMed ID: 22920801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods to enhance delivery of prandial insulin and basal-prandial insulin.
    Garber AJ
    Diabetes Obes Metab; 2013 Mar; 15 Suppl 1():11-7. PubMed ID: 23448198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
    Ilag LL; Kerr L; Malone JK; Tan MH
    Clin Ther; 2007 Jun; 29(6 Pt 1):1254-70. PubMed ID: 18036388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 2 intensification regimens with rapid-acting insulin aspart in type 2 diabetes mellitus inadequately controlled by once-daily insulin detemir and oral antidiabetes drugs: the step-wise randomized study.
    Meneghini L; Mersebach H; Kumar S; Svendsen AL; Hermansen K
    Endocr Pract; 2011; 17(5):727-36. PubMed ID: 21550957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence with rapid-acting insulin and its association with A1C level and severe hypoglycemia among elderly patients with type 2 diabetes.
    Sambamoorthi U; Garg R; Deb A; Fan T; Boss A
    Curr Med Res Opin; 2017 Jul; 33(7):1309-1316. PubMed ID: 28393573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin.
    Shaefer CF; Anderson J
    Postgrad Med; 2016 Jan; 128(1):137-44. PubMed ID: 26548422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes.
    Yacoub T
    Postgrad Med; 2017 Nov; 129(8):791-800. PubMed ID: 29032696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.
    Akturk HK; Snell-Bergeon JK; Rewers A; Klaff LJ; Bode BW; Peters AL; Bailey TS; Garg SK
    Diabetes Technol Ther; 2018 Oct; 20(10):639-647. PubMed ID: 30207748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin.
    Heinemann L; Baughman R; Boss A; Hompesch M
    J Diabetes Sci Technol; 2017 Jan; 11(1):148-156. PubMed ID: 27378794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies.
    Umpierrez GE; Bailey TS; Carcia D; Shaefer C; Shubrook JH; Skolnik N
    J Diabetes; 2018 Feb; 10(2):94-111. PubMed ID: 28581207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of inhaled technosphere insulin.
    Neumiller JJ; Campbell RK; Wood LD
    Ann Pharmacother; 2010; 44(7-8):1231-9. PubMed ID: 20516362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Acting Insulin Use and Persistence among Elderly Type 2 Diabetes Patients Adding RAI to Oral Antidiabetes Drug Regimens.
    Sambamoorthi U; Deb A; Zhou S; Garg R; Fan T; Boss A
    J Diabetes Res; 2016; 2016():5374931. PubMed ID: 27761472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technosphere insulin (Afrezza): a new, inhaled prandial insulin.
    Nuffer W; Trujillo JM; Ellis SL
    Ann Pharmacother; 2015 Jan; 49(1):99-106. PubMed ID: 25313261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approaches to rapid acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets.
    Migdal A; Abrahamson M; Peters A; Vint N
    Ann Med; 2018 Sep; 50(6):453-460. PubMed ID: 30103624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of prandial AIR inhaled insulin alone to intensified insulin glargine alone and to AIR insulin plus intensified insulin glargine in patients with type 2 diabetes previously treated with once-daily insulin glargine.
    Rosenstock J; Eliaschewitz FG; Heilmann CR; Muchmore DB; Hayes RP; Belin RM
    Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S63-73. PubMed ID: 19772451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for Initiating Use of Afrezza Inhaled Insulin in Individuals with Type 1 Diabetes.
    Pettus J; Santos Cavaiola T; Edelman SV
    Diabetes Technol Ther; 2018 Jun; 20(6):448-451. PubMed ID: 29901406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need?
    McGill JB; Ahn D; Edelman SV; Kilpatrick CR; Santos Cavaiola T
    Adv Ther; 2016 Aug; 33(8):1267-78. PubMed ID: 27384191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.